Overview

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
To evaluate whether dexpramipexole prolongs the QTc interval when orally administered to healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Knopp Biosciences
Treatments:
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Pramipexole